Viewing Study NCT02259556


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-01-04 @ 3:27 AM
Study NCT ID: NCT02259556
Status: RECRUITING
Last Update Posted: 2016-01-28
First Post: 2014-10-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas
Sponsor: Chinese PLA General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module